BPCL reported an EBITDA of Rs 13.8bn in 2QFY17 led by lower GRM (inventory impact is not disclosed) and product inventory losses of Rs 3.6bn. Higher other income (write-back of prior provisions of Rs 2.3bn) resulted in RPAT of Rs 13.1bn. Results are not comparable owing to inventory and forex impacts.